Higher CHA2DS2-VASc Score Is Associated With Increased Mortality in Acute XXXX .

@entity1 @entity64 @entity1151 @entity1031 @entity955 @entity1211
BACKGROUND: CHA2DS2-VASc score has been validated in risk prediction for @entity64 and @entity1031 in @entity1 with @entity955 ( @entity955 ). Association of CHA2DS2-VASc score with higher risk of @entity1211 and @entity1151 ( @entity1151 ) has also been shown. In this study, we investigated the long-term prognostic value of CHA2DS2-VASc score in @entity1 with @entity1151 ( @entity1151 ). METHODS: Consecutive @entity1 with @entity1151 presenting to our emergency department were retrospectively recruited. @entity1 with @entity955 and who died secondary to causes other than @entity1151 were excluded from the study. The CHA2DS2-VASc score and @entity1151 severity index (PESI) were calculated. RESULTS: Two hundred seventy seven @entity1 were included in the study. The mortality rate was 18.7%. Twenty-two cases died within 30 days, and 30 cases died during the follow-up period (median: 13 months). The mean CHA2DS2-VASc score was significantly higher in dead @entity1 compared to survivors (3.61    1.35 vs 1.95    1.52, P < .01). In multivariate regression analysis, systolic pulmonary artery pressure (hazard ratio [HR]: 1.03, 95% confidence interval [CI]: 1.01-1.06, P = .02), PESI score (HR: 1.010, 95% CI: 1.004-1.017, P < .01), and CHA2DS2-VASc score (HR: 1.67, 95% CI: 1.19-2.16, P < .01) were found to be independently correlated with mortality. The @entity1 whose CHA2DS2-VASc score was between 1 and 3 had 5.67 times and @entity1 whose CHA2DS2-VASc score was >= 4 had 16.8 times higher risk of mortality compared to @entity1 with CHA2DS2-VASc score = 0. CONCLUSION: @entity1 with higher CHA2DS2-VASc scores had higher rates of mortality after @entity1151 .
